3.17 (-0.07%)
As of Aug 31, 2021
Source:
We are a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Prior to the closing of the Merger (as defined below), we focused exclusively on developing novel approaches to modulate the immune system.
Country | United States |
Headquarters | fort collins, colorado |
Phone Number | (888) 613-8802 |
Industry | manufacturing |
CEO | Michael Handley |
Website | staterabiopharma.com |